comparemela.com

Latest Breaking News On - Point pharmaceuticals - Page 7 : comparemela.com

EyePoint Pharmaceuticals (NASDAQ:EYPT) Stock Price Passes Above Two Hundred Day Moving Average of $17.27

EyePoint Pharmaceuticals (NASDAQ:EYPT) Stock Price Passes Above Two Hundred Day Moving Average of $17.27
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Darioa-paggiarino
Deutsche-bank
Tower-research-capital
Insider-transactions-at-eyepoint-pharmaceuticals
Nasdaq
Securities-exchange-commission
Jpmorgan-chase-co
American-international-group-inc
Eyepoint-pharmaceuticals-inc

Brokerages Set EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Price Target at $33.86

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has received an average recommendation of “Buy” from the seven brokerages that are presently covering the stock, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year […]

United-states
American
Darioa-paggiarino
Tower-research-capital
Securities-exchange-commission
Analyst-recommendations-for-eyepoint-pharmaceuticals
Institutional-investors-weigh-in-on-eyepoint-pharmaceuticals
American-international-group-inc
Nasdaq
News-ratings-for-eyepoint-pharmaceuticals-daily
Investment-advisers

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives $33.86 Consensus Price Target from Brokerages

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has been assigned a consensus rating of “Buy” from the seven ratings firms that are presently covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokers that have issued ratings on the stock […]

Darioa-paggiarino
Analyst-recommendations-for-eyepoint-pharmaceuticals
News-ratings-for-eyepoint-pharmaceuticals-daily
Franklin-resources-inc
Securities-exchange-commission
Vanguard-group-inc
Jpmorgan-chase-co
Eyepoint-pharmaceuticals
Eyepoint-pharmaceuticals-inc
Pricet-rowe-associates-inc
Eyepoint-pharmaceuticals-price-performance

1,210 Shares in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Bought by FNY Investment Advisers LLC

FNY Investment Advisers LLC bought a new stake in shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) in the 4th quarter, HoldingsChannel reports. The fund bought 1,210 shares of the company’s stock, valued at approximately $27,000. Several other institutional investors have also recently added to or reduced their stakes in the business. Deutsche Bank […]

Canada
United-states
American
Darioa-paggiarino
Cubist-systematic-strategies
Fny-investment-advisers
Eyepoint-pharmaceuticals-stock-performance
Nasdaq
News-ratings-for-eyepoint-pharmaceuticals-daily
Deutsche-bank
Quarter-for-eyepoint-pharmaceuticals

FNY Investment Advisers LLC Buys Shares of 1,210 EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)

FNY Investment Advisers LLC purchased a new stake in shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 1,210 shares of the company’s stock, valued at approximately $27,000. Other hedge funds have also recently […]

Darioa-paggiarino
Fny-investment-advisers
Nasdaq
Eyepoint-pharmaceuticals-stock-performance
News-ratings-for-eyepoint-pharmaceuticals-daily
Barclays-plc
Scotia-capital-inc
Jpmorgan-chase-co
Panagora-asset-management-inc
Quarter-for-eyepoint-pharmaceuticals
Eyepoint-pharmaceuticals

vimarsana © 2020. All Rights Reserved.